Relevance of pharmacogenomics and multidisciplinary management in a young-elderly patient with kras mutant colorectal cancer treated with first-line aflibercept-containing chemotherapy

HIGHLIGHTS

• who: Gemma Bruera from the Oncology Territorial Care, SSalvatore Hospital, Oncology Network ASL1, University of L`Aquila, L`Aquila, Italy have published the article: Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy, in the Journal: (JOURNAL) of 06/02/2020
• what: In clinical practice, a complex management evaluating patientrelated clinical parameters and RAS/BRAF genotype of patients with MCRC, particularly the elderly and/or those who are unfit because of comorbidities, is required to properly tailor multidisciplinary medical and surgical . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.